Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Cipla USA Inc., priced at $0.1519 per ML under NDC 69097090443. Its NADAC has been published 120 times since Nov 8, 2023.

FDA first approved this application on Aug 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

OSELTAMIVIR PHOSPHATE
$0.1519per ML

Strength

6 mg/mL

Manufacturer

Cipla USA Inc.

NDC

69097090443

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

2/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212858

FDA Approved

8/30/2021

TE Code

AB

On Market Since

1/16/2023

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 120 times since Nov 8, 2023, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1519 per ML
All-time high$0.2776 (Jan 10, 2024)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1711
52-week low$0.1519
Median price$0.1982
Average price$0.1981
Largest weekly change+38.5% (Dec 18, 2024)
Weeks tracked120
Tracking sinceNov 8, 2023

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-11.2%

3Y

-40.8%

5Y

N/A

All

-40.8%

Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Cipla USA Inc., is $0.1519 per ML (NDC 69097090443), effective Feb 18, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 40.8%. It has been tracked across 120 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Nov 8, 2023, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.2776 (Jan 10, 2024), with a median of $0.1982 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 69097090443) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.